In addition, ETV4 interacting with LOXL2 could synergistically promote the expression of targeted genes such as NID1 through mediating DNA methylation, which will further lead to the cell proliferation and metastasis of CRC by the activation of ERK signaling pathway (Fig.10). Here, LOXL2 is linked to colorectal carcinoma.